Mary Theresa Coelho

Mary Theresa Coelho (finance chief) discloses dealings in 6 companies, chiefly Biodelivery Sciences International Inc, Inotiv, Inc. and Balchem Corp. In total, 19 filings cover trades dated from 15 February 2018 to 19 July 2026.

The open-market side counts 1 purchase for €1,412 alongside 5 sales for €282k. Sales outweigh purchases by €281k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 8 share grants and 4 option exercises.

On 20 July 2026 came the latest disclosure, a transaction in Inotiv, Inc. The clock since the last published purchase (13 January 2022) now reads 1,745 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.